This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (99)  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in JAMA  Topic Collections  • Pulmonary Diseases, Other  • Prostate Disease  • Review  • Oncology  • Alert me on articles by topic

A Meta-analysis

Krista M. Dale, PharmD; Craig I. Coleman, PharmD; Nickole N. Henyan, PharmD; Jeffrey Kluger, MD; C. Michael White, PharmD

JAMA. 2006;295:74-80.

Context  Statins are cholesterol-lowering drugs that have been proven in randomized controlled trials to prevent cardiac events. Recent retrospective analyses have suggested that statins also prevent cancer.

Objectives  To investigate the effect of statin therapy on cancer incidence and cancer death and to analyze the effect of statins on specific cancers and the effect of statin lipophilicity or derivation.

Data Sources  A systematic literature search of MEDLINE, EMBASE, CINAHL, Web of Science, CANCERLIT, and the Cochrane Systematic Review Database through July 2005 was conducted using specific search terms. A review of cardiology and cancer abstracts and manual review of references was also performed.

Study Selection  Twenty-seven of the 8943 articles (n = 86 936 participants) initially identified met the inclusion criteria, reporting 26 randomized controlled trials of statins, with a mean duration of follow-up of at least 1 year, enrolling a minimum of 100 patients, and reporting data on either cancer incidence (n = 20 studies) or cancer death (n = 22 studies).

Data Extraction  All data were independently extracted by 3 investigators using a standardized data abstraction tool. Weighted averages were reported as odds ratios (ORs) with 95% confidence intervals (CIs) using a random-effects model (DerSimonian and Laird methods). Statistical heterogeneity scores were assessed with the Q statistic.

Data Synthesis  In meta-analyses including 6662 incident cancers and 2407 cancer deaths, statins did not reduce the incidence of cancer (OR, 1.02; 95% CI, 0.97-1.07) or cancer deaths (OR, 1.01; 95% CI, 0.93-1.09). No reductions were noted for any individual cancer type. This null effect on cancer incidence persisted when only hydrophilic, lipophilic, naturally derived, or synthetically derived statins were evaluated.

Conclusions  Statins have a neutral effect on cancer and cancer death risk in randomized controlled trials. We found that no type of cancer was affected by statin use and no subtype of statin affected the risk of cancer.

Author Affiliations: University of Connecticut School of Pharmacy, Storrs (Drs Dale, Coleman, Henyan, and White); University of Connecticut School of Medicine, Farmington (Dr Kluger); and Divisions of Cardiology (Drs Dale, Coleman, Henyan, Kluger, and White) and Drug Information (Drs Dale, Coleman, Henyan, and White), Hartford Hospital, Hartford, Conn.

RELATED LETTERS

Statins and the Risk of Cancer
Robin E. Duncan, Ahmed El-Sohemy, and Michael C. Archer
JAMA. 2006;295(23):2720.
EXTRACT | FULL TEXT  

Statins and the Risk of Cancer
Michael R. Freeman, Keith R. Solomon, and Mark Moyad
JAMA. 2006;295(23):2720-2721.
EXTRACT | FULL TEXT  

Statins and the Risk of Cancer
Claudia A. Salinas, Ilir Agalliu, Janet L. Stanford, and Daniel W. Lin
JAMA. 2006;295(23):2721.
EXTRACT | FULL TEXT  

Statins and the Risk of Cancer—Reply
Krista Dale and C. Michael White
JAMA. 2006;295(23):2721-2722.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Statin Use and Risk of Prostate Cancer: Results from a Population-based Epidemiologic Study
Agalliu et al.
Am J Epidemiol 2008;0:kwn141v1-kwn141.
ABSTRACT | FULL TEXT  

Prevention of Prostate Cancer: What We Know and Where We Are Going
Jayachandran and Freedland
American Journal of Men's Health 2008;2:178-189.
ABSTRACT  

Estrogen Receptor-Negative Breast Cancer Is Less Likely to Arise among Lipophilic Statin Users
Kumar et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1028-1033.
ABSTRACT | FULL TEXT  

Statins, Breast Cancer, and an Invisible Switch?
Byers
Cancer Epidemiol. Biomarkers Prev. 2008;17:1026-1027.
FULL TEXT  

Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women: Analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA Study)
Mizuno et al.
Circulation 2008;117:494-502.
ABSTRACT | FULL TEXT  

The Association Between Statins and Cancer Incidence in a Veterans Population
Farwell et al.
JNCI J Natl Cancer Inst 2008;100:134-139.
ABSTRACT | FULL TEXT  

Statin Induces Apoptosis and Cell Growth Arrest in Prostate Cancer Cells
Hoque et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:88-94.
ABSTRACT | FULL TEXT  

Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis.
Afilalo et al.
J Am Coll Cardiol 2008;51:37-45.
ABSTRACT | FULL TEXT  

Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study
Murtola et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:2226-2232.
ABSTRACT | FULL TEXT  

Sequence Variation in Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease Gene, Low LDL Cholesterol, and Cancer Incidence
Folsom et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:2455-2458.
ABSTRACT | FULL TEXT  

Statin Use and Risk of Prostate Cancer in the California Men's Health Study Cohort
Flick et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:2218-2225.
ABSTRACT | FULL TEXT  

Epidemiologic Musing on Statin Drugs in the Prevention of Advanced Prostate Cancer
Platz
Cancer Epidemiol. Biomarkers Prev. 2007;16:2175-2180.
FULL TEXT  

Long-Term Follow-up of the West of Scotland Coronary Prevention Study
Ford et al.
NEJM 2007;357:1477-1486.
ABSTRACT | FULL TEXT  

Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis
Shachaf et al.
Blood 2007;110:2674-2684.
ABSTRACT | FULL TEXT  

Statins and the Risk of Colorectal Cancer: A Meta-Analysis of 18 Studies Involving More Than 1.5 Million Patients
Bonovas et al.
JCO 2007;25:3462-3468.
ABSTRACT | FULL TEXT  

Do Statins Affect Androgen Levels in Men? Results from the Boston Area Community Health Survey
Hall et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1587-1594.
ABSTRACT | FULL TEXT  

Efficacy and Safety of Statin Monotherapy in Older Adults: A Meta-Analysis
Roberts et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2007;62:879-887.
ABSTRACT | FULL TEXT  

Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer: Insights From Large Randomized Statin Trials
Alsheikh-Ali et al.
J Am Coll Cardiol 2007;50:409-418.
ABSTRACT | FULL TEXT  

Statins and Lung Cancer Risk
Gray et al.
Chest 2007;131:1274-1275.
FULL TEXT  

Cancer Chemoprevention: How Do We Know What Works?
Neugut et al.
JCO 2007;25:1461-1462.
FULL TEXT  

Tocotrienols Potentiate Lovastatin-Mediated Growth Suppression In Vitro and In Vivo
McAnally et al.
Exp. Biol. Med. 2007;232:523-531.
ABSTRACT | FULL TEXT  

Cholesterol Starvation Induces Differentiation of Human Leukemia HL-60 Cells
Sanchez-Martin et al.
Cancer Res. 2007;67:3379-3386.
ABSTRACT | FULL TEXT  

Vision for a Global Registry of Anticipated Public Health Studies
Choi et al.
Am. J. Public Health 2007;97:S82-S87.
ABSTRACT | FULL TEXT  

Pravastatin and cancer: an unproven association
Brophy
CMAJ 2007;176:646-647.
FULL TEXT  

Does pravastatin promote cancer in elderly patients? A meta-analysis
Bonovas and Sitaras
CMAJ 2007;176:649-654.
ABSTRACT | FULL TEXT  

Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis
Tanaka et al.
Int Immunol 2007;19:163-173.
ABSTRACT | FULL TEXT  

The Use of Statins in Pediatrics: Knowledge Base, Limitations, and Future Directions
Belay et al.
Pediatrics 2007;119:370-380.
ABSTRACT | FULL TEXT  

Statin Use and Risk of Colorectal Cancer
Coogan et al.
JNCI J Natl Cancer Inst 2007;99:32-40.
ABSTRACT | FULL TEXT  

Statins and the Risk of Lung, Breast, and Colorectal Cancer in the Elderly
Setoguchi et al.
Circulation 2007;115:27-33.
ABSTRACT | FULL TEXT  

Statin Drugs and Risk of Advanced Prostate Cancer
Platz et al.
JNCI J Natl Cancer Inst 2006;98:1819-1825.
ABSTRACT | FULL TEXT  

Risk of Multiple Myeloma following Medication Use and Medical Conditions: A Case-Control Study in Connecticut Women
Landgren et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:2342-2347.
ABSTRACT | FULL TEXT  

The Year in Epidemiology, Health Services Research, and Outcomes Research
Krumholz and Masoudi
J Am Coll Cardiol 2006;48:1886-1895.
FULL TEXT  

Statins, Fibrates, and Melanoma Risk: a Systematic Review and Meta-analysis.
Freeman et al.
JNCI J Natl Cancer Inst 2006;98:1538-1546.
ABSTRACT | FULL TEXT  

Statin and Cancer Risks: From Tasseomancy of Epidemiologic Studies to Meta-Analyses
Kim
JCO 2006;24:4796-4797.
FULL TEXT  

Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
Sivaprasad et al.
Molecular Cancer Therapeutics 2006;5:2310-2316.
ABSTRACT | FULL TEXT  

A 39-year-old woman with hypercholesterolemia.
Mittleman
JAMA 2006;296:319-326.
ABSTRACT | FULL TEXT  

JournalScan
Gut 2006;55:1036-1036.
FULL TEXT  

Statins and the Risk of Cancer
Duncan et al.
JAMA 2006;295:2720-2720.
FULL TEXT  

Statins and the Risk of Cancer
Salinas et al.
JAMA 2006;295:2721-2721.
FULL TEXT  

Statins and the Risk of Cancer
Freeman et al.
JAMA 2006;295:2720-2721.
FULL TEXT  

Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward
Kelloff et al.
Clin. Cancer Res. 2006;12:3661-3697.
ABSTRACT | FULL TEXT  

Statins, Diet, and Low Cholesterol--Reply
Cannon
JAMA 2006;295:2479-2480.
FULL TEXT  

Breast Cancer Prevention: Time for Randomized Controlled Trials With Statins--Reply
Eliassen and Hankinson
Arch Intern Med 2006;166:1144-1144.
FULL TEXT  

Statins Do Not Affect Cancer Risk
Journal Watch Cardiology 2006;2006:7-7.
FULL TEXT